(+)-catechin multiple interactions ISO RGD:731016 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of PLA2G2A mRNA CTD PMID:24763279 1,2-dimethylhydrazine increases expression ISO RGD:731017 6480464 1, 2-Dimethylhydrazine results in increased expression of PLA2G2A mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO RGD:731017 6480464 Ethinyl Estradiol affects the expression of PLA2G2A mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO RGD:731017 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PLA2G2A mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:731017 6480464 Ethinyl Estradiol results in increased expression of PLA2G2A mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:731016 6480464 Estradiol results in increased expression of PLA2G2A protein CTD PMID:18191855 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLA2G2A mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLA2G2A mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:731017 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PLA2G2A mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PLA2G2A mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PLA2G2A mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:731016 6480464 Tetrachlorodibenzodioxin results in increased expression of PLA2G2A mRNA CTD PMID:20106945 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PLA2G2A mRNA CTD PMID:20566336 2,3,7,8-Tetrachlorodibenzofuran increases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4,6-trinitrobenzenesulfonic acid multiple interactions ISO RGD:731017 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PLA2G2A mRNA] CTD PMID:18200517 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:731017 6480464 Trinitrobenzenesulfonic Acid results in increased expression of PLA2G2A mRNA CTD PMID:17982090 , PMID:18200517 2-amino-2-deoxy-D-glucopyranose multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of PLA2G2A mRNA], IL1B inhibits the reaction [Glucosamine results in decreased expression of PLA2G2A mRNA] CTD PMID:17109745 2-amino-2-deoxy-D-glucopyranose decreases expression EXP 6480464 Glucosamine results in decreased expression of PLA2G2A mRNA CTD PMID:17109745 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:731016 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PLA2G2A mRNA CTD PMID:28628672 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PLA2G2A mRNA CTD PMID:24835565 5-aza-2'-deoxycytidine increases expression ISO RGD:731016 6480464 Decitabine results in increased expression of PLA2G2A mRNA, Decitabine results in increased expression of PLA2G2A protein CTD PMID:18320072 , PMID:18953428 5-aza-2'-deoxycytidine affects expression ISO RGD:731016 6480464 Decitabine affects the expression of PLA2G2A mRNA CTD PMID:23300844 5-aza-2'-deoxycytidine multiple interactions ISO RGD:731016 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [IFNG protein promotes the reaction [Decitabine results in increased expression of PLA2G2A protein]] more ... CTD PMID:18953428 5-aza-2'-deoxycytidine decreases methylation ISO RGD:731016 6480464 Decitabine results in decreased methylation of PLA2G2A promoter CTD PMID:18953428 acetic acid multiple interactions ISO RGD:731017 6480464 Melitten inhibits the reaction [Acetic Acid results in increased expression of PLA2G2A protein] CTD PMID:33002459 acetic acid increases expression ISO RGD:731017 6480464 Acetic Acid results in increased expression of PLA2G2A protein CTD PMID:33002459 aflatoxin B1 increases methylation ISO RGD:731016 6480464 Aflatoxin B1 results in increased methylation of PLA2G2A gene CTD PMID:27153756 aflatoxin M1 decreases expression ISO RGD:731016 6480464 Aflatoxin M1 results in decreased expression of PLA2G2A mRNA CTD PMID:30928695 aldehydo-D-glucosamine multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of PLA2G2A mRNA], IL1B inhibits the reaction [Glucosamine results in decreased expression of PLA2G2A mRNA] CTD PMID:17109745 aldehydo-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of PLA2G2A mRNA CTD PMID:17109745 all-trans-retinoic acid increases expression ISO RGD:731016 6480464 Tretinoin results in increased expression of PLA2G2A mRNA CTD PMID:16249480 , PMID:23830798 amiodarone increases expression EXP 6480464 Amiodarone results in increased expression of PLA2G2A mRNA CTD PMID:25580480 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PLA2G2A mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of PLA2G2A mRNA CTD PMID:30779732 anthocyanin increases expression EXP 6480464 Anthocyanins results in increased expression of PLA2G2A mRNA CTD PMID:18803703 antirheumatic drug decreases expression ISO RGD:731016 6480464 Antirheumatic Agents results in decreased expression of PLA2G2A mRNA CTD PMID:24449571 baicalein multiple interactions ISO RGD:731017 6480464 baicalein inhibits the reaction [PLA2G2A protein results in increased expression of PTGS2 protein] more ... CTD PMID:31811862 belinostat increases expression ISO RGD:731016 6480464 belinostat results in increased expression of PLA2G2A mRNA CTD PMID:26272509 belinostat multiple interactions ISO RGD:731016 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G2A mRNA CTD PMID:27188386 benzo[a]pyrene affects methylation ISO RGD:731016 6480464 Benzo(a)pyrene affects the methylation of PLA2G2A promoter CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:731016 6480464 Benzo(a)pyrene results in increased methylation of PLA2G2A 5' UTR CTD PMID:27901495 beta-D-glucosamine multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of PLA2G2A mRNA], IL1B inhibits the reaction [Glucosamine results in decreased expression of PLA2G2A mRNA] CTD PMID:17109745 beta-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of PLA2G2A mRNA CTD PMID:17109745 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:731016 6480464 Diethylhexyl Phthalate results in decreased expression of PLA2G2A mRNA CTD PMID:28412506 , PMID:31163220 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of PLA2G2A mRNA CTD PMID:25181051 bisphenol A decreases methylation ISO RGD:731017 6480464 bisphenol A results in decreased methylation of PLA2G2A promoter CTD PMID:27312807 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of PLA2G2A mRNA CTD PMID:19167457 cadmium atom decreases expression ISO RGD:731016 6480464 Cadmium results in decreased expression of PLA2G2A mRNA CTD PMID:24376830 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of PLA2G2A mRNA CTD PMID:25808797 calcium atom increases uptake EXP 6480464 PLA2G2A protein results in increased uptake of Calcium CTD PMID:15695168 calcium atom multiple interactions EXP 6480464 BQ 788 inhibits the reaction [EDN3 protein inhibits the reaction [PLA2G2A protein affects the uptake of Calcium]], EDN3 protein inhibits the reaction [PLA2G2A protein affects the uptake of Calcium] CTD PMID:15695168 calcium(0) increases uptake EXP 6480464 PLA2G2A protein results in increased uptake of Calcium CTD PMID:15695168 calcium(0) multiple interactions EXP 6480464 BQ 788 inhibits the reaction [EDN3 protein inhibits the reaction [PLA2G2A protein affects the uptake of Calcium]], EDN3 protein inhibits the reaction [PLA2G2A protein affects the uptake of Calcium] CTD PMID:15695168 CGP 52608 multiple interactions ISO RGD:731016 6480464 CGP 52608 promotes the reaction [RORA protein binds to PLA2G2A gene] CTD PMID:28238834 chromium(6+) affects expression ISO RGD:731017 6480464 chromium hexavalent ion affects the expression of PLA2G2A mRNA CTD PMID:28472532 ciglitazone multiple interactions ISO RGD:731016 6480464 [ciglitazone binds to PPARG protein alternative form] which results in increased expression of PLA2G2A mRNA CTD PMID:16197558 cisplatin affects expression ISO RGD:731016 6480464 Cisplatin affects the expression of PLA2G2A mRNA CTD PMID:23300844 clothianidin increases expression ISO RGD:731016 6480464 clothianidin results in increased expression of PLA2G2A mRNA CTD PMID:31626844 colforsin daropate hydrochloride multiple interactions ISO RGD:731016 6480464 Colforsin inhibits the reaction [IFNG protein promotes the reaction [decitabine results in increased expression of PLA2G2A protein]] CTD PMID:18953428 curcumin multiple interactions ISO RGD:731017 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PLA2G2A mRNA] CTD PMID:18200517 cyclosporin A decreases expression ISO RGD:731016 6480464 Cyclosporine results in decreased expression of PLA2G2A mRNA CTD PMID:20106945 , PMID:21632981 cyclosporin A decreases methylation ISO RGD:731016 6480464 Cyclosporine results in decreased methylation of PLA2G2A promoter CTD PMID:27989131 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of PLA2G2A mRNA CTD PMID:14618091 dexamethasone multiple interactions ISO RGD:731016 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PLA2G2A mRNA CTD PMID:28628672 dexamethasone increases expression ISO RGD:731016 6480464 Dexamethasone results in increased expression of PLA2G2A mRNA CTD PMID:25047013 dextran sulfate increases expression ISO RGD:731017 6480464 Dextran Sulfate results in increased expression of PLA2G2A mRNA CTD PMID:23894361 dibenzofuran multiple interactions EXP 6480464 AHR protein promotes the reaction [dibenzofuran analog results in increased expression of PLA2G2A mRNA] CTD PMID:20566336 dibenzofuran increases expression EXP 6480464 dibenzofuran analog results in increased expression of PLA2G2A mRNA CTD PMID:20566336 dimethyl sulfoxide decreases expression ISO RGD:731016 6480464 Dimethyl Sulfoxide results in decreased expression of PLA2G2A mRNA CTD PMID:21878375 dimethylarsinic acid multiple interactions ISO RGD:731017 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PLA2G2A mRNA CTD PMID:34876320 diuron decreases expression EXP 6480464 Diuron results in decreased expression of PLA2G2A mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:731016 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 EC 3.1.1.4 (phospholipase A2) inhibitor multiple interactions ISO RGD:731016 6480464 Phospholipase A2 Inhibitors inhibits the reaction [IL1B protein results in increased expression of PLA2G2A mRNA], Phospholipase A2 Inhibitors inhibits the reaction [IL1B protein results in increased secretion of PLA2G2A protein] CTD PMID:19765281 EC 3.1.1.4 (phospholipase A2) inhibitor decreases expression ISO RGD:731016 6480464 Phospholipase A2 Inhibitors results in decreased expression of PLA2G2A mRNA CTD PMID:19765281 ellagic acid decreases expression ISO RGD:731016 6480464 Ellagic Acid results in decreased expression of PLA2G2A mRNA CTD PMID:20816778 entinostat multiple interactions ISO RGD:731016 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G2A mRNA CTD PMID:27188386 entinostat increases expression ISO RGD:731016 6480464 entinostat results in increased expression of PLA2G2A mRNA CTD PMID:26272509 erythromycin A decreases expression ISO RGD:731017 6480464 Erythromycin results in decreased expression of PLA2G2A mRNA CTD PMID:27503388 ethanol multiple interactions EXP 6480464 Docosahexaenoic Acids inhibits the reaction [Ethanol results in increased expression of PLA2G2A protein] more ... CTD PMID:25029343 , PMID:29339456 ethanol increases expression EXP 6480464 Ethanol results in increased expression of PLA2G2A protein CTD PMID:25029343 , PMID:29339456 fenvalerate decreases expression EXP 6480464 fenvalerate results in decreased expression of PLA2G2A mRNA CTD PMID:30307764 furan increases expression EXP 6480464 furan results in increased expression of PLA2G2A mRNA CTD PMID:27387713 genistein decreases expression ISO RGD:731016 6480464 Genistein results in decreased expression of PLA2G2A mRNA CTD PMID:20816778 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of PLA2G2A mRNA CTD PMID:33387578 ibuprofen affects expression ISO RGD:731016 6480464 Ibuprofen affects the expression of PLA2G2A mRNA CTD PMID:17070997 indometacin multiple interactions ISO RGD:731016 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PLA2G2A mRNA CTD PMID:28628672 kaempferol 3-O-beta-D-galactoside affects activity ISO RGD:731016 6480464 kaempferol-3-O-galactoside affects the activity of PLA2G2A protein CTD PMID:8190018 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of PLA2G2A mRNA CTD PMID:11578147 lidocaine decreases expression EXP 6480464 Lidocaine results in decreased expression of PLA2G2A mRNA CTD PMID:35283115 lipopolysaccharide increases expression ISO RGD:731017 6480464 Lipopolysaccharides results in increased expression of PLA2G2A mRNA CTD PMID:29248447 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of PLA2G2A mRNA, Lipopolysaccharides results in increased expression of PLA2G2A protein CTD PMID:21943492 lipopolysaccharide multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PLA2G2A mRNA more ... CTD PMID:21943492 lipopolysaccharide increases expression ISO RGD:731016 6480464 Lipopolysaccharides results in increased expression of PLA2G2A protein CTD PMID:15964894 lipopolysaccharide multiple interactions ISO RGD:731016 6480464 [Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of PLA2G2A mRNA CTD PMID:21878375 lycopene multiple interactions ISO RGD:731016 6480464 lycopene inhibits the reaction [HMGB1 protein results in increased expression of and results in increased secretion of PLA2G2A protein] CTD PMID:22429818 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of PLA2G2A mRNA CTD PMID:28801915 mangiferin decreases activity ISO RGD:731016 6480464 mangiferin results in decreased activity of PLA2G2A protein CTD PMID:15177302 melittin multiple interactions ISO RGD:731017 6480464 Melitten inhibits the reaction [Acetic Acid results in increased expression of PLA2G2A protein] CTD PMID:33002459 methotrexate increases expression ISO RGD:731016 6480464 Methotrexate results in increased expression of PLA2G2A mRNA CTD PMID:17400583 methylarsonic acid multiple interactions ISO RGD:731017 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PLA2G2A mRNA CTD PMID:34876320 mithramycin multiple interactions ISO RGD:731016 6480464 Plicamycin inhibits the reaction [IFNG protein promotes the reaction [decitabine results in increased expression of PLA2G2A protein]] CTD PMID:18953428 N'-Nitrosonornicotine increases expression EXP 6480464 N'-nitrosonornicotine results in increased expression of PLA2G2A mRNA CTD PMID:24835565 N-nitrosodiethylamine increases expression ISO RGD:731016 6480464 Diethylnitrosamine results in increased expression of PLA2G2A mRNA CTD PMID:21527772 nickel atom increases expression ISO RGD:731016 6480464 Nickel results in increased expression of PLA2G2A mRNA CTD PMID:25583101 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of PLA2G2A mRNA CTD PMID:33484710 olaparib multiple interactions EXP 6480464 olaparib inhibits the reaction [Ethanol results in increased expression of PLA2G2A protein] CTD PMID:29339456 paclitaxel increases expression EXP 6480464 Paclitaxel results in increased expression of PLA2G2A mRNA CTD PMID:18754875 panobinostat multiple interactions ISO RGD:731016 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G2A mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:731016 6480464 panobinostat results in increased expression of PLA2G2A mRNA CTD PMID:26272509 paracetamol decreases expression ISO RGD:731016 6480464 Acetaminophen results in decreased expression of PLA2G2A mRNA CTD PMID:29067470 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of PLA2G2A mRNA CTD PMID:33387578 paraquat increases expression EXP 6480464 Paraquat results in increased expression of PLA2G2A mRNA CTD PMID:32680482 phenethyl caffeate multiple interactions ISO RGD:731016 6480464 caffeic acid phenethyl ester inhibits the reaction [IFNG protein promotes the reaction [decitabine results in increased expression of PLA2G2A protein]] CTD PMID:18953428 phenobarbital increases expression ISO RGD:731017 6480464 Phenobarbital results in increased expression of PLA2G2A mRNA CTD PMID:19482888 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of PLA2G2A mRNA CTD PMID:19162173 phenobarbital multiple interactions ISO RGD:731017 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of PLA2G2A mRNA] CTD PMID:19482888 phenylephrine decreases expression EXP 6480464 Phenylephrine results in decreased expression of PLA2G2A mRNA CTD PMID:18158353 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:731016 6480464 Tetradecanoylphorbol Acetate inhibits the reaction [IFNG protein promotes the reaction [decitabine results in increased expression of PLA2G2A protein]] CTD PMID:18953428 phosgene increases activity EXP 6480464 Phosgene results in increased activity of PLA2G2A protein CTD PMID:19235614 pirinixic acid decreases expression ISO RGD:731017 6480464 pirinixic acid results in decreased expression of PLA2G2A mRNA CTD PMID:17426115 prostaglandin E2 increases expression ISO RGD:731016 6480464 Dinoprostone results in increased expression of PLA2G2A protein CTD PMID:15964894 quercetagetin affects activity ISO RGD:731016 6480464 quercetagetin affects the activity of PLA2G2A protein CTD PMID:8190018 quercetin decreases expression ISO RGD:731016 6480464 Quercetin results in decreased expression of PLA2G2A mRNA CTD PMID:20816778 quercetin increases expression ISO RGD:731016 6480464 Quercetin results in increased expression of PLA2G2A mRNA CTD PMID:21632981 resveratrol multiple interactions ISO RGD:731016 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of PLA2G2A mRNA CTD PMID:23557933 rofecoxib affects expression ISO RGD:731016 6480464 rofecoxib affects the expression of PLA2G2A mRNA CTD PMID:17070997 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of PLA2G2A mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:731016 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 scutellarin affects activity ISO RGD:731016 6480464 scutellarin affects the activity of PLA2G2A protein CTD PMID:8190018 simvastatin multiple interactions EXP 6480464 Simvastatin inhibits the reaction [Cholesterol, Dietary results in increased expression of PLA2G2A protein] CTD PMID:19237014 sodium arsenate multiple interactions ISO RGD:731017 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PLA2G2A mRNA CTD PMID:34876320 sodium arsenite affects methylation ISO RGD:731016 6480464 sodium arsenite affects the methylation of PLA2G2A gene CTD PMID:28589171 sodium arsenite multiple interactions ISO RGD:731017 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PLA2G2A mRNA CTD PMID:34876320 sodium arsenite increases expression ISO RGD:731016 6480464 sodium arsenite results in increased expression of PLA2G2A mRNA CTD PMID:34032870 sodium arsenite decreases expression ISO RGD:731017 6480464 sodium arsenite results in decreased expression of PLA2G2A mRNA CTD PMID:22700541 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of PLA2G2A mRNA CTD PMID:22561333 tamoxifen affects expression ISO RGD:731017 6480464 Tamoxifen affects the expression of PLA2G2A mRNA CTD PMID:17555576 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLA2G2A mRNA CTD PMID:32741896 tetracycline decreases expression ISO RGD:731017 6480464 Tetracycline results in decreased expression of PLA2G2A mRNA CTD PMID:16917069 thromboxane A2 increases abundance ISO RGD:731016 6480464 PLA2G2A protein results in increased abundance of Thromboxane A2 metabolite CTD PMID:10027849 thromboxane A2 multiple interactions ISO RGD:731016 6480464 varespladib inhibits the reaction [PLA2G2A protein results in increased abundance of Thromboxane A2 metabolite] CTD PMID:10027849 thromboxane B2 increases abundance ISO RGD:731016 6480464 PLA2G2A protein results in increased abundance of Thromboxane B2 CTD PMID:10027849 thromboxane B2 multiple interactions ISO RGD:731016 6480464 varespladib inhibits the reaction [PLA2G2A protein results in increased abundance of Thromboxane B2] CTD PMID:10027849 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of PLA2G2A mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:731016 6480464 trichostatin A results in increased expression of PLA2G2A mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:731016 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G2A mRNA CTD PMID:27188386 triclosan increases expression ISO RGD:731016 6480464 Triclosan results in increased expression of PLA2G2A mRNA CTD PMID:30510588 ursodeoxycholic acid multiple interactions EXP 6480464 Ursodeoxycholic Acid inhibits the reaction [Azoxymethane results in increased activity of PLA2G2A protein] more ... CTD PMID:10025872 valproic acid affects expression ISO RGD:731016 6480464 Valproic Acid affects the expression of PLA2G2A mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:731016 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G2A mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:731016 6480464 Valproic Acid results in increased expression of PLA2G2A mRNA CTD PMID:23179753 more ... vanadium atom increases expression ISO RGD:731016 6480464 Vanadium results in increased expression of PLA2G2A mRNA CTD PMID:19000753 vanadium(0) increases expression ISO RGD:731016 6480464 Vanadium results in increased expression of PLA2G2A mRNA CTD PMID:19000753 varespladib decreases activity EXP 6480464 varespladib results in decreased activity of PLA2G2A protein CTD PMID:10027849 varespladib decreases activity ISO RGD:731016 6480464 varespladib results in decreased activity of PLA2G2A protein CTD PMID:10027849 varespladib multiple interactions ISO RGD:731016 6480464 varespladib inhibits the reaction [PLA2G2A protein results in increased abundance of Thromboxane A2 metabolite], varespladib inhibits the reaction [PLA2G2A protein results in increased abundance of Thromboxane B2] CTD PMID:10027849 varespladib methyl multiple interactions ISO RGD:731016 6480464 varespladib methyl inhibits the reaction [IL1B protein results in increased secretion of PLA2G2A protein] CTD PMID:19765281 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of PLA2G2A mRNA CTD PMID:19015723 vorinostat multiple interactions ISO RGD:731016 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G2A mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:731016 6480464 vorinostat results in increased expression of PLA2G2A mRNA CTD PMID:26272509
